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IntroductIon
Obesity is associated with increased prevalences of cardiovascu-
lar risk factors (1) and a lower life expectancy (2). The increas-
ing prevalence of overweight and obesity are also observed in 
younger age groups, including adolescents and infants, high-
lighting the importance of the need to identify management 
strategies for effective public health interventions. Nonsurgical 
management of obesity often involves a cognitive-behavioral 
approach (3,4) aimed at changing unhealthy lifestyles, adopt-
ing a healthy dietary model, and increasing regular physical 
activity. Clinical studies have demonstrated that nonopera-
tive treatments for obesity aimed at maintaining a stable body 
weight can prevent obesity-related comorbidities (5).
The measurement of carotid intima-media thickness (c-IMT) 
can add incremental information to risk factor assessment (6). 
Increased c-IMT is a well-known marker of subclinical athero-
sclerosis that correlates with cardiovascular risk factors (7), 
severity of coronary atherosclerosis (8), and has been shown 
to predict cardiovascular events (9). Despite a need to reduce 
such obesity-related complications, long-term treatment 
effects have only been demonstrated for bariatric surgery (10) 
or for subjects treated medically with impaired glucose toler-
ance (11). The purpose of this study was to determine whether 
1-year medical treatment with cognitive-behavioral approach 
in obese subjects without comorbidities influences long-term 
10-year c-IMT.
Methods and Procedures
Patient selection
A total of 251 subjects (age range: 18–65 years; BMI range: 28–40 kg/m2) 
were selected among those seen in 1999 at the Obesity and Metabolic 
Diseases Outpatient Department of the Division of Internal Medicine 
of the Partinico’s Civil Hospital (AUSL 6, Palermo), a community hos-
pital 50 km from Palermo, Italy. We also included a cohort of 90 subjects 
that answered a public announcement for participating in a previous 
study (12) designed to estimate the long-term effects of the cognitive-
behavioral treatment of obesity. The characteristics of this subgroup are 
described elsewhere (12). The remaining 161 patients were referred to 
the hospital spontaneously or by their family doctors.
We excluded subjects at baseline with a diagnosis of diabetes and 
hypertension, any systemic or end organ disease on the basis of clinical 
history, use of any pharmacological treatment, physical examination, rou-
tine blood tests, and electrocardiogram. Atherosclerotic vascular disease 
was excluded using echo-doppler examination of the carotid arteries, 
abdominal aorta, and iliac-femoral-popliteal arteries. Subjects who had 
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a change of ±2 kg in body weight in the previous 3 months, those who 
followed a dietary treatment for weight loss during the last year, and 
pregnant women were excluded. The diagnosis of diabetes was defined 
according to the American Diabetes Association criteria (13). All subjects 
underwent a 1-year medical nutritional therapy (MNT) with a cogni-
tive-behavioral approach (14). Subjects were re-evaluated at 10-years 
between April and June 2009; 54 subjects were interviewed by telephone 
and subsequently returned to the centre for a clinical examination. The 
participant flow diagram is presented in Figure 1. Informed consent was 
obtained by all subjects. The study was performed according to the prin-
ciples of the Helsinki declaration and approved by the Ethics Committee 
of the University of Palermo and the Committee for the Protection of 
Human Subjects of Dartmouth College.
Medical nutrition therapy
Participants attended clinical visits weekly for 3 months, then biweekly 
for the next 3 months and monthly for the subsequent 6 months (20–24 
visits in a year). At each visit anthropometric measurements were per-
formed and subjects received nutritional and behavioral counseling. In 
general, participants regularly met a registered dietitian and psycho-
logical support was offered, they could also meet in small groups in the 
hospital. Furthermore, subjects participated during the first 3 months 
of treatment to four classroom sessions concerning healthy eating and 
strategies designed to improve adherence to the nutritional program. 
Various strategies and problem solving were tailored to each individual 
at each visit. Suggestions were offered about healthy cooking and prep-
aration of foods according to standardized procedure organized in a 
booklet program. In general, the diet proposed provided a daily caloric 
intake of about 20 kcal/kg of actual body weight comprising of ~1,500–
2,500 kcal/day with no supplementation (i.e., multivitamin, mineral 
salts, or antioxidants) was given. Macronutrient distribution provided 
carbohydrates 55%, lipids 25% (20% saturated, 65% monounsaturated 
and 15% polyunsaturated), proteins 20% of total calorie intake, a daily 
intake of about 30 g of fibers and of cholesterol lower than 250 mg. 
Subjects were counseled to engage in regular physical exercise but no 
specific activities or interventions were advocated.
Dropout was defined as a patient abandoning treatment during the 
first 3 months or in subjects whose body weight loss was <5% during 
this period of time. Success was defined as a weight loss ≥5% (15,16) at 1 
year from starting the MNT. Ten years after the MNT, subjects were cat-
egorized as “success” if body weight was equal or lower than the baseline 
value, or as a “failure” if body weight increased ≥0.5 kg. Participants who 
were initially classified as having dropped-out or those with an unsuc-
cessful initial weight loss attempt were also reconsidered in the analysis 
at 10 years.
Measurements
Each subject was assessed before beginning the weight loss program. A 
fasting blood sample was drawn for glucose, cholesterol, high-density 
lipoprotein cholesterol, triglycerides, uric acid, and other routine bio-
chemical measurements. Height, body weight, systolic and diastolic 
arterial blood pressure (two measurements obtained at 5 min of inter-
val in seated position) were measured by nurses or dietitians according 
to standardized procedures. The 54 subjects re-evaluated in 2009 were 
asked to submit to blood work performed in territorial laboratories 
during the last 6 months. Fat mass (% body weight) and fat-free mass 
(kg) were estimated as previously described (17) by means of bioelectri-
cal impedance analysis (BIA-103, RJL, Detroit/Akern, Florence, Italy). 
Body circumferences were measured at the umbilicus (waist circum-
ference) and at the most prominent buttock level (hip circumference); 
their ratio (waist-to-hip ratio) was used as an indirect index of body-
fat distribution. A 12-lead ECG (Esaote, Genova, Italy) was obtained 
in all subjects. Images of the right and left extracranial carotid artery 
walls were obtained in several projections by a high-resolution ultra-
sonographic 10-MHz linear array probe (Acuson, Malven, PA in 1999; 
Sonoline G50, Siemens, Germany in 2009); end-diastolic IMT of the 
far wall of both common carotid arteries was measured 10 mm caudal 
to the bulb, using two-dimensional longitudinal sections of the vessel 
and the distance from the first echogenic line to the second echogenic 
line (three values for each carotid artery using antero-posterior, latero-
lateral, and postero-anterior scans); the highest value was considered 
for calculations (18). A single-blinded experienced physician was 
responsible for performing the carotid ultrasonographic examinations 
both in 1999 and in 2009 (S.B.), using a manual method; the between-
day intraobserver variability is 4.6% for this operator. The 1999 IMT 
images were not reread in 2009 since the registrations (VHS) were not 
available.
statistical analysis
All data are expressed as mean ± s.e.m. The variables considered in 
the study were normally distributed on the basis of the Shapiro–Wilk 
test; specifically, for 10-year c-IMT the coefficient of 0.966 with a P = 
0.102 was obtained. The Student’s t-test for unpaired data was used to 
compare the means of two groups. The χ2 test was applied to compare 
frequencies between groups. The Student’s t-test for paired data was 
used to compare changes with time of measures in the same group. 
The relationships between variables were tested by the Pearson’s 
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coefficients of correlation. Exploratory analyses were performed to 
assess the predictors of 10-year c-IMT but also to assess the strength 
and independency of associations between variables using multiple 
regression analysis (stepwise backward selection). A P value of <0.05 
was considered as statistically significant. We utilized SYSTAT statis-
tical software (Windows version, release 12.0; Systat Software, San 
Jose, CA) for all analyses.
results
A total of 251 subjects underwent MNT for obesity at base-
line and 98 (39%) dropped-out (Figure 1); the remaining 153 
(61%) subjects completed the treatment. Among completers, 
in 112 subjects (73.2%) a successful weight loss was observed 
at 6 months. Twelve months after starting the MNT, successful 
weight loss was observed in 109 (71.2%) subjects; in this group, 
the average weight reduction was 9.8% (−9 ± 0.4 kg) as com-
pared to the 3.1% (−2.7 ± 0.2 kg) in the group where the MNT 
was considered a failure (P < 0.001). Ten years after the MNT, 40 
subjects were classified as failure and 14 as a success. Five sub-
jects who were initially classified as dropout were included in the 
success group 10 years later, 18 dropout subjects were included 
in the failure group. The number of treatments of hypocaloric 
diets (either prescribed or self-prescribed) between the two 
observation periods (1999–2009), did not differ between the 
two groups (failure group: 1.7 ± 0.2 vs. success group: 1.7 ± 1.3; 
P = 0.933). The demographic and clinical characteristics of the 
two subgroups (success and failure groups) at baseline and at 10 
years are reported in Table 1. No clinical cardiovascular disease 
manifestations were reported in either group during follow-up, 
no new carotid plaques were observed at 10-year echographic 
evaluation. Ten years after MNT, c-IMT significantly increased 
(0.06 ± 0.02 mm; P = 0.004) in the failure group and significantly 
decreased (−0.07 ± 0.03 mm; P = 0.027) in the success group. 
Ten-year change in c-IMT correlated significantly with 10-year 
change in body weight (Figure 2). The 10-year c-IMT was signif-
icantly correlated with the 10-year BMI (r = 0.32; P = 0.017) but 
not with the 10-year body weight (r = 0.26; P = 0.057). Table 2 
reports the independent predictors of the 10-year c-IMT. The 
1-year success of medical nutrition therapy did not predict the 
10-year c-IMT (P = 0.374) when it was entered in the multiple 
regression analysis instead of the 10-year success.
table 1 Physical and clinical characteristics of obese subjects who underwent medical nutritional treatment and divided in two 
groups on the basis of successful weight loss at 10 years
10-year weight reduction
Success group Failure group
Pa,bInitial Final Pa Initial Final Pa
M/F 2/12 8/32
Age (years) 41.2 ± 3.7 40.5 ± 1.6c
Smokers, n (%) 3 (21.4) 3 (21.4) 0.645 12 (30.0)c 9 (22.5)d 0.611
Hypertension, n (%) 3 (21.4) 7 (50.0) 0.237 3 (7.5)c 18 (45.0)d <0.001
Diabetes, n (%) 0 1 (7.1) 1.000 0c 6 (15.0)d 0.034
Subjects on anti-hypertensives, n (%) 0 7 (50.0) 0.009 0c 18 (45.0)d <0.001
Subjects on antidiabetics, n (%) 0 1 (7.1) 1.000 0c 5 (12.5)d 0.065
Body weight (kg) 90.1 ± 6.0 84.2 ± 5.3 0.012 85.2 ± 2.5c 94.9 ± 3.1d <0.001 <0.001
BMI (kg/m2) 35.9 ± 2.6 33.6 ± 2.4 0.010 33.2 ± 0.8c 37.0 ± 1.1d <0.001 <0.001
FM % 36.1 ± 1.9 35.2 ± 2.3 0.343 33.9 ± 1.0c 39.6 ± 1.3d <0.001 0.001
Waist circumference (cm) 111 ± 6 106 ± 5 0.021 106 ± 2c 113 ± 3d <0.001 <0.001
Blood concentration of
 glucose (mg/dl) 94 ± 4 104 ± 16 0.498 91 ± 2c 92 ± 2d 0.397 0.913
 Total cholesterol (mg/dl) 199 ± 12 191 ± 11 0.324 217 ± 6c 212 ± 6d 0.286 0.814
 HDL-cholesterol (mg/dl) 41.7 ± 2.6 45.5 ± 2.6 <0.047 45.8 ± 1.5c 46.9 ± 1.8d 0.501 0.273
 Triglycerides (mg/dl) 156 ± 35 140 ± 29 0.208 115 ± 10c 127 ± 8d 0.080 0.053
 LDL-cholesterol (mg/dl) 126 ± 11 118 ± 11 0.278 148 ± 6c 139 ± 5d 0.119 0.899
 Uric acid (mg/dl) 5.3 ± 0.3 5.1 ± 0.3 0.413 4.7 ± 0.2c 5.1 ± 0.2d 0.033 0.048
Blood pressure
 Systolic (mm Hg) 133 ± 7 133 ± 6 0.957 131 ± 3c 138 ± 3d 0.004 0.257
 Diastolic (mm Hg) 84 ± 3 78 ± 3 0.108 81 ± 2c 82 ± 2d 0.322 0.060
Carotid-IMT max (mm) 0.71 ± 0.04 0.64 ± 0.03 <0.027 0.66 ± 0.02c 0.72 ± 0.03d 0.004 0.001
All values expressed as mean ± s.e.m., or count (%).
FM, fat mass; HDL, high-density lipoproteins; IMT, intima-media thickness; LDL, low density lipoproteins.
aStudent’s paired t-test or Pearson’s χ2 test, as appropriate. bInter-group (success vs. failure) differences of the changes (final minus initial) of continuous variable values. 
cP = NS vs. correspondent initial value in the success group. dP = NS vs. correspondent final value in the success group.
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dIscussIon
Strategies aimed at reducing body weight generally produce 
favorable short-term results but maintaining such weight 
loss often proves difficult to sustain in the long term (19–21). 
Furthermore, it is unknown if long-term effects of MNT effec-
tively reduces both metabolic and cardiovascular morbidity or 
mortality. Our study demonstrates that the c-IMT is lower in 
subjects who maintained or lost weight at 10 years after a MNT, 
compared to an increase in c-IMT in those who increased their 
body weight. If c-IMT is an accepted measure of subclini-
cal atherosclerosis that correlates with cardiovascular events 
(9,22,23), then the study results are in agreement with the 
hypothesis that long-term weight loss may be associated with 
a reduction of cardiovascular risk especially in those subjects 
whose c-IMT remained under the value of 0.9 mm that is actu-
ally considered the cutoff of normality for c-IMT (24).
The results concerning the 10-year c-IMT variation may in 
part be explained by the observation that in the failure group, 
the incidence of diabetes was double than that observed in the 
success subgroup, and that systolic blood pressure and uric 
acid levels increased significantly. On the contrary, the high-
density lipoprotein cholesterol blood levels increased signifi-
cantly in the success subgroup. Despite the 10-year incidence 
of both hypertension and diabetes was significantly lower 
(Table 1) in the success group, the cohort size is numerically 
too small to consider this result. However, it seems plausible 
to hypothesize that MNT of obesity is able to prevent diabe-
tes and hypertension in this at-risk cohort and consequently 
influence favourably the c-IMT. We cannot discriminate on the 
basis of our results if the favorable changes of c-IMT in the 
success group with respect to the failure group are due to the 
changes in body weight or, rather, if they are in consequence 
of a more healthy habitual nutrition. The correlation between 
10-year weight change with c-IMT change does not resolve this 
problem because body weight change may reflect nutritional 
changes. However, the multivariate analysis demonstrates that 
the group (failure vs. success) has an influence on the 10-year 
c-IMT which is independent from age and BMI suggesting 
that improving lifestyle measures per se may have a favorable 
impact on the c-IMT. In addition, we did not observe any col-
linearity among these confounders as well.
It was recently shown that intensifying behavioral treat-
ments have effects on weight loss in the middle term compa-
rable to those obtained by means of the surgical treatment of 
obesity (25). Our study demonstrates in a small patient cohort, 
that MNT of obesity using a cognitive-behavioral approach is 
successful (about 26% of treated subjects) even in the long-
term (10 years) in obese nondiabetic subjects as demonstrated 
in other studies (26,27). These results highlight the limited 
efficacy of lifestyle modifications on rates of weight loss and 
certainly much improvement would be needed from a popu-
lation-health management standpoint to further reduce these 
persistently high rates, however even small changes may impact 
c-IMT. Successful MNT of obesity can be defined by improve-
ments in metabolic and cardiovascular risk factors, and quality 
of life. These objectives can be obtained even through mod-
est amounts of weight loss (5–10% loss of initial body weight) 
(15,16,28), and further research should support identifying 
successful predictors of weight loss. In addition, over a 10-year 
period, although goals are for weight loss, one can consider 
maintenance of weight to be a success in of itself (29,30), as 
data have demonstrated that weight does increase for every 
decade of life (31).
A surprising result of this study is that the initial dropout did 
not influence the final success 10 years after the MNT. It is well 
described (32–34) that a short lasting nutritional treatment 
may give effects measured in the long run, this phenomenon 
has been indicated as vaccination effect of the initial treatment 
(35). The two subgroups at 10 years (failure and success) did 
not differ for the number of dietary treatments after the MNT 
of 1999, therefore we are induced to conclude that the vaccina-
tion effect is possible even in the case of initial dropout.
This study has inherent limitations. Only a limited part of 
the initial cohort was re-evaluated at 10 years which reduces 
study power leading to wide variations in prevalences and 
means between groups, including gender associations with 
c-IMT. However, it should be considered that larger cohorts 
are difficult to be obtained when considering the MNT of 
uncomplicated obesity in the long-term. In fact, the number of 
subjects considered in our study is similar to that reported by 
other studies that investigated the maintenance of weight loss 
table 2 Multiple stepwise linear regression analysis 
(backward selection).
Variable β-Coefficient P
10-year carotid-IMT
 Age 0.007 <0.001
 10-year BMI 0.007 <0.01
 Group (1 = success, 2 = failure) 0.082 <0.05
 Sex (1 = male, 2 = female) — 0.939
IMT, intima-media thickness.
−40 4020−20
−0.4
−0.2
0.2
0.4 ∆ c-IMT (mm)
∆ BW (kg)
r = 0.28
P = 0.040
Figure 2 Correlation between the 10-years change of body weight 
(Δ BW) and the 10-years change of carotid intima-media thickness 
(Δ c-IMT).
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following dietary treatment of uncomplicated obesity even with 
a shorter follow-up than in our study (36–39). Another major 
limitation is that >50% of subjects were lost to follow-up. This is 
somewhat unusual and high for a prospective study; however, 
we encountered problems in identifying patients’ home phone 
numbers and home addresses due largely to an increased usage 
of mobile telephones, and 30% reduction in landlines, leading 
to the tracking of such patients difficult (40,41). In addition, 
there was a tendency of high emigration (regional or national) 
in the study area (Partinico) (42). We acknowledge such num-
bers are difficult to identify and account for.
The baseline cohort was not homogeneously enrolled since 
subjects might be referred by their family doctors or volun-
tarily answered to our announcement introducing additional 
bias. However, we feel that this latter limitation did not influ-
ence the 10-year results concerning c-IMT changes and the 
success of MNT given the fact that the percentages of the two 
different recruited subjects were similar between failure and 
success group (data not shown). Although we encouraged 
physical activity as it impacts our primary outcomes, it was not 
systematically measured which may impact our results.
Other possible limitations may have affected this study. 
Although automated methods are available currently to ascer-
tain c-IMT values and reduce measurement drift (43,44), 
the original images were not originally stored for retrospec-
tive review nor were they available or validated in 1999, and 
hence manual methods were used for measurement at both 
time points. However, by using manual methods by the same 
observer, we likely mitigated observer and measurement bias, 
which would otherwise be incorporated if different methods 
have been used. Furthermore, the probability of errors are 
likely equally distributed between all participants. Other stud-
ies have reported reading variability with manual analyzing 
system and with different operators that is around 4%, a value 
that induces to consider as valid the 10-year c-IMT differences 
that we found to be higher than ±9% (−9.6% in the success vs. 
9.1% in the failure group) in our groups. In addition, there is 
some evidence that validates that well-standardized measure-
ments by trained technicians are probably as good as automated 
methods (45). We encountered issues pertaining to outdating 
of the device as well, making it challenging to retrospectively 
analyze the data or test reproducibility. We note that there are 
studies that have demonstrated <3% disagreement between 
such methods (46). Interlaboratory variability may indeed 
lead to inherent measurement bias thus limiting considerably 
the possibility of comparing the change of these variables with 
time. Finally, as the group of patients were young at baseline, 
it is not unexpected that there were few cardiovascular disease 
manifestations or deaths noted.
In conclusion, these results highlight the limited efficacy 
of lifestyle modifications on rates of weight loss and certainly 
much improvement would be needed from a population-
health management standpoint to further reduce these persist-
ently high rates. However even small changes appear to impact 
c-IMT. Further long-term studies including larger cohorts and 
clinical outcomes are necessary to obtain definitive answers.
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